Utilizing a high-sensitivity IL-11 PCR-based ELISA, we were able to demonstrate detectable IL-11 concentrations across all samples (unlike the conventional ELISA), and significantly higher levels were observed in both the plasma and serum of the NSCLC patients. The gene discussed is IL11; the disease is non-small cell lung carcinoma.